ENG/中
老虎证券
行情
交易
收费
下载
优惠与活动
帮助
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
股权激励
关于
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
Turn Therapeutics (Direct Listing)
3.33
-0.0900
-2.63%
成交量：
1,703.00
成交额：
5,778.70
市值：
9,805.25万
市盈率：
-25.83
高：
3.43
开：
3.43
低：
3.33
收：
3.42
52周最高：
26.50
52周最低：
2.57
股本：
2,944.52万
流通股本：
1,786.88万
量比：
0.42
换手率：
0.01%
股息：
- -
股息率：
- -
每股收益(TTM):
-0.1289
每股收益(LYR):
-0.0659
净资产收益率：
-2324.83%
总资产收益率：
-78.67%
市净率：
194.54
市盈率(LYR):
-50.55
数据加载中...
总览
公司
新闻资讯
公告
Turn Therapeutics公司：预计全额融资收益将支持运营至2027年底
美股速递
·
2小时前
Turn Therapeutics 任命资本市场资深专家 Andrew Scott 为企业传播副总裁
美股速递
·
2025/11/05
Turn Therapeutics与领先的医用外科产品制造和分销商Medline签署全球供应、开发和许可协议
美股速递
·
2025/10/30
Turn Therapeutics发布股东更新，强调在临床和战略里程碑上的持续进展
美股速递
·
2025/10/22
Turn Therapeutics任命Arthur Golden为董事会成员
投资观察
·
2025/10/15
异动解读 | Turn Therapeutics股东拟抛售股票，盘后大跌5.43%
异动解读
·
2025/10/10
Turn Therapeutics提交招股书，涉及股东分批出售最多700万股股票
美股速递
·
2025/10/10
美股异动 | 次新股Turn Therapeutics(TTRX.US)涨超144% 致力于开发下一代皮肤病、伤口和抗感染疗法
智通财经
·
2025/10/09
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券 | 轻松买卖美股港股A股/美债/ETF/Crypto/期权期货","description":"老虎证券提供多项优惠：港股&Crypto 0佣、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","keywords":"老虎证券,老虎证券开户,老虎证券香港,老虎证券登录,老虎证券官网,香港证券开户,证券公司开户,股票开户,香港证券公司,香港证券,证券公司,股票投资,投资app,投资平台,股票买卖,股票交易平台,股票app,证券app,新手投资","social":{"ogDescription":"老虎证券提供多项优惠：港股&Crypto 0佣、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/TTRX/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TTRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TTRX\",,,,,undefined,":{"symbol":"TTRX","market":"US","secType":"STK","nameCN":"Turn Therapeutics (Direct Listing)","latestPrice":3.33,"timestamp":1774364183535,"preClose":3.42,"halted":0,"volume":1703,"delay":0,"changeRate":-0.02631578947368417,"floatShares":17868800,"shares":29445200,"eps":-0.12892704,"marketStatus":"交易中","change":-0.09,"latestTime":"03-24 11:03:46 EDT","open":3.43,"high":3.43,"low":3.33,"amount":5778.699641,"amplitude":0.02924,"askPrice":3.43,"askSize":114,"bidPrice":3.33,"bidSize":60,"shortable":3,"etf":0,"ttmEps":-0.12892704,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1774382400000},"marketStatusCode":2,"adr":0,"listingDate":1759896000000,"exchange":"NASDAQ","adjPreClose":3.42,"postHourTrading":{"tag":"盘后","latestPrice":3.42,"preClose":3.42,"latestTime":"17:46 EDT","volume":5,"amount":17.1887,"timestamp":1774302415146,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.417675},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TTRX\",,,,,undefined,":{"symbol":"TTRX","floatShares":17868800,"roa":"-78.67%","roe":"-2324.83%","lyrEps":-0.065873,"volumeRatio":0.417675,"shares":29445200,"dividePrice":0,"high":3.43,"amplitude":0.02924,"preClose":3.42,"low":3.33,"week52Low":2.5701,"pbRate":"194.54","week52High":26.5,"institutionHeld":0,"latestPrice":3.33,"committee":-0.310345,"eps":-0.12892704,"divideRate":0,"volume":1703,"delay":0,"ttmEps":-0.12892704,"open":3.43,"prevYearClose":3.94,"prevWeekClose":3.44,"prevMonthClose":3.6,"prevQuarterClose":3.94,"fiveDayClose":3.62,"twentyDayClose":3.35,"sixtyDayClose":2.97},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TTRX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TTRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TTRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1769140800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TTRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TTRX","date":"2026-03-20","current":-26.526631,"percent":0.747748,"low":-100.764104,"twenty":-45.672425,"median":-29.706726,"eighty":-26.154329,"high":-21.019642,"avg":-35.708166,"sd":13.978655,"marketCap":100996977},"quantilePoints":[{"date":"2025-10-10","current":-100.764104,"twenty":-95.944951,"median":-88.716222,"eighty":-81.487493,"marketCap":257809999},{"date":"2025-10-17","current":-61.772777,"twenty":-80.611283,"median":-71.301556,"eighty":-62.49565,"marketCap":158048738},{"date":"2025-10-24","current":-54.215469,"twenty":-75.594983,"median":-58.815569,"eighty":-54.127848,"marketCap":138712988},{"date":"2025-10-31","current":-57.391729,"twenty":-70.118673,"median":-57.391729,"eighty":-54.25928,"marketCap":146839608},{"date":"2025-11-07","current":-46.548635,"twenty":-64.664269,"median":-55.529784,"eighty":-49.111548,"marketCap":119097010},{"date":"2025-11-14","current":-44.796216,"twenty":-60.918473,"median":-54.215469,"eighty":-46.701972,"marketCap":114613358},{"date":"2025-11-21","current":-21.019642,"twenty":-57.501255,"median":-52.517813,"eighty":-44.182869,"marketCap":79796445},{"date":"2025-11-28","current":-27.302265,"twenty":-57.501255,"median":-48.301054,"eighty":-27.302265,"marketCap":103647044},{"date":"2025-12-05","current":-32.964383,"twenty":-57.391729,"median":-47.315318,"eighty":-27.302265,"marketCap":125142027},{"date":"2025-12-12","current":-24.897804,"twenty":-55.858362,"median":-45.508136,"eighty":-26.138816,"marketCap":94519037},{"date":"2025-12-19","current":-23.268976,"twenty":-55.63931,"median":-44.029532,"eighty":-25.595874,"marketCap":88335549},{"date":"2025-12-26","current":-23.036286,"twenty":-55.464068,"median":-42.496165,"eighty":-24.137684,"marketCap":87452193},{"date":"2026-01-02","current":-30.559922,"twenty":-54.828816,"median":-32.964383,"eighty":-24.075634,"marketCap":116014021},{"date":"2026-01-09","current":-36.066913,"twenty":-54.30309,"median":-35.136154,"eighty":-24.292811,"marketCap":136920100},{"date":"2026-01-16","current":-37.385488,"twenty":-54.149753,"median":-35.834223,"eighty":-24.680627,"marketCap":141925782},{"date":"2026-01-23","current":-36.687419,"twenty":-53.711649,"median":-35.834223,"eighty":-25.083956,"marketCap":139275715},{"date":"2026-01-30","current":-33.740015,"twenty":-52.638292,"median":-35.911787,"eighty":-25.45626,"marketCap":128086546},{"date":"2026-02-06","current":-28.698404,"twenty":-50.513483,"median":-35.446407,"eighty":-25.69184,"marketCap":108947177},{"date":"2026-02-13","current":-27.806427,"twenty":-48.322959,"median":-35.097373,"eighty":-25.925975,"marketCap":105560981},{"date":"2026-02-20","current":-26.371506,"twenty":-48.027239,"median":-33.584888,"eighty":-25.643857,"marketCap":100113622},{"date":"2026-02-27","current":-29.784289,"twenty":-47.359128,"median":-32.809256,"eighty":-25.86537,"marketCap":113069502},{"date":"2026-03-06","current":-26.21638,"twenty":-47.161981,"median":-31.723371,"eighty":-25.999203,"marketCap":99524718},{"date":"2026-03-13","current":-28.892312,"twenty":-46.395298,"median":-30.559922,"eighty":-26.076766,"marketCap":109683306},{"date":"2026-03-20","current":-26.604196,"twenty":-45.672425,"median":-29.706726,"eighty":-26.154329,"marketCap":100996977}],"updateTime":1774339861217},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TTRX\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1127224911","title":"Turn Therapeutics公司：预计全额融资收益将支持运营至2027年底","url":"https://stock-news.laohu8.com/highlight/detail?id=1127224911","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127224911?lang=zh_cn&edition=fundamental","pubTime":"2026-03-24 20:05","pubTimestamp":1774353911,"startTime":"0","endTime":"0","summary":"Turn Therapeutics公司近日宣布，通过完成全额融资所获得的收益，预计将足以支撑公司运营持续至2027年年底。这一资金规划为公司的长期发展提供了稳定的财务保障。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TTRX"],"gpt_icon":0},{"id":"1112036493","title":"Turn Therapeutics 任命资本市场资深专家 Andrew Scott 为企业传播副总裁","url":"https://stock-news.laohu8.com/highlight/detail?id=1112036493","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112036493?lang=zh_cn&edition=fundamental","pubTime":"2025-11-05 06:09","pubTimestamp":1762294167,"startTime":"0","endTime":"0","summary":"Turn Therapeutics 任命资本市场资深专家 Andrew Scott 为企业传播副总裁","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TTRX"],"gpt_icon":0},{"id":"1103328553","title":"Turn Therapeutics与领先的医用外科产品制造和分销商Medline签署全球供应、开发和许可协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1103328553","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103328553?lang=zh_cn&edition=fundamental","pubTime":"2025-10-30 19:31","pubTimestamp":1761823868,"startTime":"0","endTime":"0","summary":"Turn Therapeutics与领先的医用外科产品制造和分销商Medline签署全球供应、开发和许可协议","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TTRX"],"gpt_icon":0},{"id":"1148388176","title":"Turn Therapeutics发布股东更新，强调在临床和战略里程碑上的持续进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1148388176","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148388176?lang=zh_cn&edition=fundamental","pubTime":"2025-10-22 20:03","pubTimestamp":1761134630,"startTime":"0","endTime":"0","summary":"Turn Therapeutics发布股东更新，强调在临床和战略里程碑上的持续进展","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TTRX"],"gpt_icon":0},{"id":"1150228317","title":"Turn Therapeutics任命Arthur Golden为董事会成员","url":"https://stock-news.laohu8.com/highlight/detail?id=1150228317","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150228317?lang=zh_cn&edition=fundamental","pubTime":"2025-10-15 00:09","pubTimestamp":1760458140,"startTime":"0","endTime":"0","summary":"加利福尼亚州韦斯特莱克村，2025年10月14日——Turn Therapeutics是一家处于临床阶段的生物技术公司，专注于开发下一代皮肤病学、创伤护理和抗感染疗法。公司宣布任命Arthur Golden为董事会成员，他是一位资深企业董事会顾问，在并购交易、股东关系、合规和治理方面拥有丰富经验。他拥有数十年的企业董事经验，最近担任Emerson Electric董事24年，并担任企业治理和财务委员会主席，同时是执行委员会成员。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TTRX","LENZ","BK4539","BK4139"],"gpt_icon":0},{"id":"1135785184","title":"异动解读 | Turn Therapeutics股东拟抛售股票，盘后大跌5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=1135785184","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135785184?lang=zh_cn&edition=fundamental","pubTime":"2025-10-10 04:34","pubTimestamp":1760042075,"startTime":"0","endTime":"0","summary":"周四盘后交易时段，Turn Therapeutics（股票代码：TTRX）股价大幅下跌5.43%，引发投资者关注。\n\n消息面上，Turn Therapeutics于当日提交了一份招股说明书，披露公司股东计划分批出售最多700万股股票。这一举动可能会增加市场上流通的股票数量，从而对股价造成压力。\n\n分析人士指出，股东大规模减持往往被市场视为对公司未来发展缺乏信心的信号。此外，增加的股票供给可能会导致股价下跌。投资者对这一消息反应强烈，导致Turn Therapeutics股价在盘后交易中出现显著跌幅。然而，具体影响还需进一步观察，因为实际售股数量和时间表尚未确定。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TTRX"],"gpt_icon":0},{"id":"1171585948","title":"Turn Therapeutics提交招股书，涉及股东分批出售最多700万股股票","url":"https://stock-news.laohu8.com/highlight/detail?id=1171585948","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171585948?lang=zh_cn&edition=fundamental","pubTime":"2025-10-10 04:18","pubTimestamp":1760041095,"startTime":"0","endTime":"0","summary":"Turn Therapeutics提交招股书，涉及股东分批出售最多700万股股票。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TTRX"],"gpt_icon":0},{"id":"2574255164","title":"美股异动 | 次新股Turn Therapeutics(TTRX.US)涨超144% 致力于开发下一代皮肤病、伤口和抗感染疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=2574255164","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574255164?lang=zh_cn&edition=fundamental","pubTime":"2025-10-09 23:51","pubTimestamp":1760025108,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周四，次新股Turn Therapeutics(TTRX.US)股价上涨，截至发稿，该股涨超144%，报16.95美元。Turn Therapeutics致力于开发下一代皮肤病、伤口和抗感染疗法。该公司拥有一种专有的递送平台技术 “PermaFusion®”，该技术旨在让水溶性的活性成分在无需乳化剂的情况下，以油性载体渗透进入皮肤、指甲或黏膜，从而增强可用性和减少刺激性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1353369.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4139","LENZ","BK4007","BK4539","TTRX"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}]}}